脊髓星形细胞瘤的中枢神经系统播散:与H3 K27M突变的关联
该回顾性研究纳入2011至2022年按2021年WHO分类诊断的94例脊髓星形细胞瘤患者,分析中枢神经系统播散的特征与影响因素。5年随访总体播散率达85.0%,H3 K27改变患者5年播散率95.2%显著高于野生型68.0%(p=0.002)。多因素分析显示H3 K27M改变似为播散危险因素(HR 2.089,95%CI 0.940-4.642,p=0.070)。
要点
- 94例脊髓星形细胞瘤5年随访总体中枢神经系统播散率达85.0%。
- H3 K27改变患者5年播散率95.2%,显著高于野生型的68.0%(p=0.002)。
- H3 K27改变患者播散后中位生存8.83个月,显著短于野生型的13.40个月(p=0.008)。
核心结论
- 提示肿瘤恶性度更高的因素(H3 K27M改变、更高组织病理分级、Ki-67指数≥10%、肿瘤长度≥4个椎体节段)同样提示更高的播散率。
- 播散的发生与脊髓星形细胞瘤患者的结局事件密切相关。
研究设计与样本
- 回顾性纳入2011至2022年按2021年WHO分类诊断的94例脊髓星形细胞瘤患者,收集临床与病理特征并分析影响播散的因素。
主要发现
- 94例患者5年随访总体中枢神经系统播散率达85.0%,播散包括软脑膜播散和(或)蛛网膜下腔种植。
- H3 K27改变患者5年中枢神经系统播散率为95.2%,显著高于H3 K27野生型患者的68.0%(p=0.002)。
- H3 K27改变患者无播散生存期中位数为14.37个月(95%CI 2.84-25.89),显著短于H3 K27野生型患者(原文注明未计算统计量;p<0.001)。
- 单因素Cox回归分析中,H3 K27M改变、更高组织病理分级、Ki-67指数(≥10%)和肿瘤长度(≥4个椎体节段)被确定为与脊髓星形细胞瘤中枢神经系统播散相关的潜在因素。
- 多因素Cox回归分析显示H3 K27M改变似为该现象的危险因素(HR 2.089,95%CI 0.940-4.642,p=0.070)。
关键数值与推荐
- H3 K27改变患者播散后中位生存8.83个月(95%CI 7.13-10.54),显著短于H3 K27野生型患者的13.40个月(95%CI 3.98-34.26)(p=0.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with spinal cord astrocytomas (SCAs) are at high risk for CNS dissemination, yet comprehensive data on characteristics of dissemination are lacking. This study depicts the exact incidence and patterns of dissemination by analyzing data from a large-scale dataset of SCA. METHODS: The authors included 94 patients with SCA based on the 2021 WHO classification from 2011 to 2022, retrospectively collected their clinical and pathological characteristics, and analyzed factors influencing SCA dissemination. RESULTS: CNS dissemination, encompassing leptomeningeal spreading and/or subarachnoid seeding, was evaluated in 94 patients with and without H3 K27 alterations, with an overall dissemination rate reaching 85.0% at 5-year follow-up. Patients with altered H3 K27 had a significantly higher 5-year CNS dissemination rate than patients with H3 K27 wildtype status (95.2% vs 68.0%, p = 0.002). The median dissemination-free survival in H3 K27-altered patients was 14.37 (95% CI 2.84-25.89) months, significantly shorter than those with H3 K27 wildtype (statistics not calculated; p < 0.001). Based on univariate Cox regression analysis, H3 K27M alteration, higher histopathological grade, Ki-67 index (≥ 10%), and tumor length (≥ 4 segments) were identified as potential factors associated with CNS dissemination in SCAs. Multivariate Cox regression analysis revealed that H3 K27M alteration appeared to be a risk factor for this phenomenon (HR 2.089, 95% CI 0.940-4.642, p = 0.070). Following dissemination, H3 K27-altered patients had a median postdissemination survival of 8.83 (95% CI 7.13-10.54) months, which was significantly shorter than the 13.40 (95% CI 3.98-34.26) months in those with H3 K27 wildtype (p = 0.008). CONCLUSIONS: Factors indicative of higher SCA malignancy, such as H3 K27M alteration, higher histopathological grade, Ki-67 index (≥ 10%), and tumor length (≥ 4 segments), were similarly suggestive of higher rates of dissemination. The occurrence of dissemination is closely associated with the outcome events in patients with SCA.
引用
- An S, Lin H, Zhang Y, et al. Central nervous system dissemination in spinal cord astrocytomas: association with H3 K27M mutation. J Neurosurg Spine. 2024. PMID: 39303298. doi:10.3171/2024.6.SPINE24233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。